Medtech company Becton, Dickinson and Company has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its BD Vaginal Panel on the BD COR System. The comprehensive diagnostic test detects the three most common infectious causes of vaginitis using BD’s molecular diagnostic platform for large laboratories. The BD Vaginal Panel is a microbiome-based polymerase chain reaction (PCR) assay that…
